Johnson & Johnson (JNJ)
155.36 +2.11 (+1.38%) 04/02/25 [NYSE]
154.51 x 500 155.39 x 100
Realtime by (Cboe BZX)
154.51 x 500 155.39 x 100
Realtime 154.52 -0.84 (-0.54%) 19:27 ET
for Wed, Apr 2nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 88,821,000 | 85,159,000 | 79,990,000 | 78,740,000 | 82,584,000 |
Cost of Goods | 27,471,000 | 26,553,000 | 24,596,000 | 23,402,000 | 28,427,000 |
Gross Profit | 61,350,000 | 58,606,000 | 55,394,000 | 55,338,000 | 54,157,000 |
Operating Expenses | 44,663,000 | 43,544,000 | 36,035,000 | 36,160,000 | 37,660,000 |
Operating Income | 16,687,000 | 15,062,000 | 19,359,000 | 19,178,000 | 16,497,000 |
Interest Expense | 2,087,000 | 2,033,000 | 766,000 | 236,000 | 312,000 |
Other Income | 2,087,000 | 2,033,000 | 766,000 | 236,000 | 312,000 |
Pre-tax Income | 16,687,000 | 15,062,000 | 19,359,000 | 19,178,000 | 16,497,000 |
Income Tax | 2,621,000 | 1,736,000 | 2,989,000 | 1,377,000 | 1,783,000 |
Net Income Continuous | 14,066,000 | 13,326,000 | 16,370,000 | 17,801,000 | 14,714,000 |
Net Income Discontinuous | N/A | 21,827,000 | 1,571,000 | 3,077,000 | N/A |
Net Income | $14,066,000 | $35,153,000 | $17,941,000 | $20,878,000 | $14,714,000 |
EPS Basic Total Ops | 5.84 | 13.88 | 6.83 | 7.93 | 5.59 |
EPS Basic Continuous Ops | 5.84 | 5.26 | 6.23 | 6.76 | 5.59 |
EPS Basic Discontinuous Ops | N/A | 8.62 | 0.60 | 1.17 | N/A |
EPS Diluted Total Ops | 5.79 | 13.72 | 6.73 | 7.81 | 5.51 |
EPS Diluted Continuous Ops | 5.79 | 5.20 | 6.14 | 6.66 | 5.51 |
EPS Diluted Discontinuous Ops | N/A | 8.52 | 0.59 | 1.15 | N/A |
EPS Diluted Before Non-Recurring Items | 9.98 | 9.92 | 10.15 | 9.80 | 8.03 |
EBITDA(a) | $26,113,000 | $24,581,000 | $27,095,000 | $26,804,000 | $24,040,000 |